\-\ Texto\\:\\ \ \(0\)\
\-\ markedly\\ decreased\\ vision\\,\\ o\\.d\\.\ \(0\)\
\-\ surgery\ \(977\)\
\-\ \\â\\€\\¢\\ curvilinear\\ plaque\\,\\ posterior\\ chamber\\ of\\ right\\ globe\ \(1\)\
\-\ \\â\\€\\¢\\ high\\ signal\\ on\\ t1\ \(0\)\
\-\ \\â\\€\\¢\\ low\\ signal\\ on\\ t2\ \(0\)\
\-\ \\â\\€\\¢\\ the\\ periphery\\ of\\ the\\ lesion\\ enhances\\ with\\ contrast\ \(1\)\
\-\ ocular\\ melanoma\ \(1\)\
\-\ \\â\\€\\¢\\ primary\\ ocular\\ melanoma\ \(0\)\
\-\ \\â\\€\\¢\\ retinal\\ metastasis\\ \\(including\\ metastatic\\ melanoma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ retinoblastoma\ \(1\)\
\-\ 60\\ y\\.o\\.\\ man\\ with\\ loss\\ of\\ vision\\ of\\ the\\ right\\ eye\\ 5\\ years\\ ago\\,\\ after\\ an\\ injury\\ from\\ acid\\ fluid\\.\ \(1\)\
\-\ orbital\\ malignant\\ melanoma\\ is\\ the\\ most\\ common\\ intraocular\\ malignancy\\ in\\ adults\\;\\ \\ melanin\\ makes\\ the\\ tumor\\ hyperintense\\ on\\ t1w\\ \\ and\\ \ \(0\)\
\-\ hypointense\\ on\\ t2w\\ images\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ melanoma\\:\\ 0\\.17800698480461183\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.11192959654256342\ \(0\)\
\-\ ocular\\:\\ 0\\.10567208702530842\ \(0\)\
\-\ o\\.d\\:\\ 0\\.08288133921843421\ \(0\)\
\-\ vision\\:\\ 0\\.08057110150022276\ \(0\)\
\-\ intraocular\\:\\ 0\\.06645850337726991\ \(0\)\
\-\ melanin\\:\\ 0\\.06645850337726991\ \(0\)\
\-\ chamber\\:\\ 0\\.06378131700515266\ \(0\)\
\-\ retinoblastoma\\:\\ 0\\.0599089739265312\ \(0\)\
\-\ retinal\\:\\ 0\\.058413020108246755\ \(0\)\
\-\ plaque\\:\\ 0\\.05257098752894747\ \(0\)\
\-\ acid\\:\\ 0\\.051110774838736515\ \(0\)\
\-\ globe\\:\\ 0\\.050667049206698365\ \(0\)\
\-\ curvilinear\\:\\ 0\\.050241817610774196\ \(0\)\
\-\ t1w\\:\\ 0\\.05003566753610563\ \(0\)\
\-\ t2w\\:\\ 0\\.04887925237991172\ \(0\)\
\-\ periphery\\:\\ 0\\.048698644450326\ \(0\)\
\-\ makes\\:\\ 0\\.048346744694497734\ \(0\)\
\-\ signal\\:\\ 0\\.04598110878107711\ \(0\)\
\-\ adults\\:\\ 0\\.04450174620115296\ \(0\)\
\-\ orbital\\:\\ 0\\.041360658052742263\ \(0\)\
\-\ hypointense\\:\\ 0\\.041360658052742263\ \(0\)\
\-\ markedly\\:\\ 0\\.04127381428062074\ \(0\)\
\-\ enhances\\:\\ 0\\.041187703376071104\ \(0\)\
\-\ 60\\:\\ 0\\.038040021313613406\ \(0\)\
\-\ eye\\:\\ 0\\.036575610276652154\ \(0\)\
\-\ hyperintense\\:\\ 0\\.03620061494799153\ \(0\)\
\-\ malignancy\\:\\ 0\\.03369479263062771\ \(0\)\
\-\ metastasis\\:\\ 0\\.032640278839795166\ \(0\)\
\-\ ago\\:\\ 0\\.03245641653874743\ \(0\)\
\-\ malignant\\:\\ 0\\.03151704771815613\ \(0\)\
\-\ including\\:\\ 0\\.03148386368360126\ \(0\)\
\-\ on\\:\\ 0\\.029546571933282775\ \(0\)\
\-\ injury\\:\\ 0\\.02779804634580408\ \(0\)\
\-\ t1\\:\\ 0\\.027637709553308607\ \(0\)\
\-\ decreased\\:\\ 0\\.02592608574208734\ \(0\)\
\-\ primary\\:\\ 0\\.025830451662200982\ \(0\)\
\-\ years\\:\\ 0\\.025604521806311044\ \(0\)\
\-\ 5\\:\\ 0\\.025511841045348604\ \(0\)\
\-\ loss\\:\\ 0\\.025310858902739177\ \(0\)\
\-\ y\\.o\\:\\ 0\\.025167137067211225\ \(0\)\
\-\ fluid\\:\\ 0\\.024782031679631153\ \(0\)\
\-\ t2\\:\\ 0\\.024679477232146446\ \(0\)\
\-\ low\\:\\ 0\\.024246612784351015\ \(0\)\
\-\ high\\:\\ 0\\.023862714908947095\ \(0\)\
\-\ common\\:\\ 0\\.02281905318322854\ \(0\)\
\-\ metastatic\\:\\ 0\\.021950095955266227\ \(0\)\
\-\ surgery\\:\\ 0\\.02117345984041097\ \(0\)\
\-\ \\;\\:\\ 0\\.020667563147475445\ \(0\)\
\-\ man\\:\\ 0\\.02062175350091836\ \(0\)\
\-\ tumor\\:\\ 0\\.02032890103684501\ \(0\)\
\-\ most\\:\\ 0\\.020130970833959958\ \(0\)\
\-\ posterior\\:\\ 0\\.020098352537780088\ \(0\)\
\-\ contrast\\:\\ 0\\.01951811925314189\ \(0\)\
\-\ right\\:\\ 0\\.01840064712470238\ \(0\)\
\-\ after\\:\\ 0\\.018040828598053085\ \(0\)\
\-\ lesion\\:\\ 0\\.017760767612249536\ \(0\)\
\-\ images\\:\\ 0\\.016727182570911776\ \(0\)\
\-\ from\\:\\ 0\\.012922813399532778\ \(0\)\
\-\ an\\:\\ 0\\.012057804737599284\ \(0\)\
\-\ \\,\\:\\ 0\\.008287042821957778\ \(0\)\
\-\ \\(\\:\\ 0\\.007371038022896535\ \(0\)\
\-\ \\)\\:\\ 0\\.007280996858299031\ \(0\)\
\-\ the\\:\\ 0\\.0070535349338584595\ \(0\)\
\-\ is\\:\\ 0\\.005737661003925771\ \(0\)\
\-\ of\\:\\ 0\\.004755257175428099\ \(0\)\
\-\ in\\:\\ 0\\.00429997173612505\ \(0\)\
\-\ with\\:\\ 0\\.0023878403283650964\ \(0\)\
\-\ and\\:\\ 0\\.0018368265891042699\ \(0\)\
\-\ \\.\\:\\ 0\\.0010867204927759065\ \(0\)\
